Press release
Adeno-Associated Virus Vectors Manufacturing Market to Reach USD 2.79 Billion by 2030, Fueled by Cell-Line Shifts and Asia-Pacific Expansion
Adeno-Associated Virus Vectors Manufacturing Market Size & Trends | Mordor Intelligence
The Adeno-Associated Virus (AAV) Vectors Manufacturing Market is set to grow from USD 1.82 billion in 2025 to USD 2.79 billion by 2030, representing a solid CAGR of 8.9% as forecasted by Mordor Intelligence. This growth is propelled by expanding clinical adoption of in vivo gene therapies and bolstered regulatory support. Notably, the FDA has set an ambitious goal of approving 10-20 gene therapies annually, which is encouraging investment in manufacturing capacity.
In addition, strategic moves by key players-such as Lonza's acquisition of Roche's Vacaville facility and Thermo Fisher's optimization of its vector manufacturing footprint-are reshaping capacity and supply dynamics within the industry.
Report Overview: https://www.mordorintelligence.com/industry-reports/adeno-associated-virus-vectors-manufacturing-market?utm_source=openpr
Key Trends
Cell-line innovation reshaping manufacturing workflows
Producer cell lines are gaining popularity over traditional HEK293 systems. They simplify workflows by eliminating multi-plasmid transfection steps, improving consistency and enabling more streamlined production operations.
Purification techniques are evolving toward cost-efficiency
While affinity chromatography remains the default choice for its selectivity and yield, alternatives like ion-exchange chromatography are gaining traction. These options offer lower cost and greater scalability, easing pressure on supply and cost of goods.
Therapeutic focus shifting beyond the eye
Ophthalmology continues to lead AAV vector use due to favorable anatomical and immunological traits. However, neurology is rapidly gaining ground thanks to new capsids engineered for blood-brain barrier penetration-opening up treatment options for CNS disorders.
CDMOs expanding share amid outsourcing surge
Contract Development and Manufacturing Organizations (CDMOs) are capturing growth as pharma and biotech companies increasingly outsource vector production. Their rising share reflects the industry prioritizing efficiency and scalability.
Asia-Pacific emerges as the growth engine
Asia-Pacific is poised to be the fastest-growing region. Governments in markets like China, South Korea, and India are heavily investing in biomanufacturing capacity, while CDMO ecosystems are being actively developed to capture global demand.
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/adeno-associated-virus-vectors-manufacturing-market?utm_source=openpr
Market Segmentation
By Vector Type
Single-stranded AAV Vectors
Self-complementary AAV Vectors
By Production Platform
HEK293 Cell Platform
Sf9/Baculovirus System
Producer Cell Line (PCL)
Other Systems
By Purification Method
Affinity Chromatography
Ion Exchange Chromatography
Ultrafiltration / Diafiltration
CsCl Gradient Centrifugation
By Therapeutic Area
Ophthalmology
Neurology
Hematology
Musculoskeletal
Metabolic Disorders
Oncology
Other Therapeutic Areas
By End-User
Pharma & Biotech Companies
CDMOs / CMOs
Academic & Research Institutes
By Region:
North America
Europe
Asia‐Pacific
South America
Middle East & Africa
Explore Our Full Library of Healthcare Industry Research Reports
https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=openpr
Key Players
The AAV manufacturing market shows a medium level of concentration. Major players include:
Creative Biogene
F. Hoffmann-La Roche Ltd
GenScript
Lonza
WuXi AppTec
These organizations continue to scale through acquisitions, tech integration, and infrastructure investments, reinforcing their dominance in the vector manufacturing landscape.
Conclusion
The AAV Vectors Manufacturing Market is on track to growth from approximately USD 1.82 billion in 2025 to USD 2.79 billion by 2030, at a CAGR of 8.9%, driven by increasing gene therapy adoption and strategic capacity expansions.
The market is pivoting toward more efficient platforms and cost-effective techniques: self-complementary vectors and producer-cell lines offer performance and operational efficiency gains. Purification is shifting toward scalable, cost-sensitive methods, and therapeutic expansion beyond ophthalmology-especially into neurology-is opening new revenue streams.
CDMOs are securing a growing proportion of manufacturing through specialized service offerings, while Asia-Pacific becomes the main growth hub for infrastructure development. North America remains dominant, but Asia-Pacific's trajectory signals a shift in global production dynamics.
For complete market analysis, visit the Mordor Intelligence page: https://www.mordorintelligence.com/industry-reports/adeno-associated-virus-vectors-manufacturing-market?utm_source=openpr
Industry Related Reports
Adeno-Associated Virus (AAV) CDMO Market: The AAV CDMO market report segments the industry into By Workflow (Upstream Processing, Downstream Processing), By Culture Type (Adherent Culture, Suspension Culture), By Application (Cell & Gene Therapy Development, Vaccine Development, Biopharmaceutical & Pharmaceutical Discovery, and more), By End User (Pharmaceutical & Biopharmaceutical Companies, Academic & Research Institutes), and Geography.
Get more insights: https://www.mordorintelligence.com/industry-reports/adeno-associated-virus-aav-cdmo-market?utm_source=openpr
Gene Vector Market: The Gene Vector Market Report is Segmented by Vector Type (Viral Vectors Including AAV, Lentivirus, and More), Delivery Method (In-Vivo and Ex-Vivo), Therapy Area (Oncology, Genetic Disorders, and More), End User (Biopharma Companies, and More), Production Workflow (Upstream and Downstream), and Geography (North America, Europe, Asia-Pacific, MEA, South America).
Get more insights: https://www.mordorintelligence.com/industry-reports/gene-vector-market?utm_source=openpr
Viral Vector Contract Development and Manufacturing Organization (CDMO) Market: The Viral Vector CDMO Market report segments the industry into By Vector Type (Adenovirus, Retrovirus, Adeno-Associated Virus, Lentivirus, Others), By Workflow (Upstream Manufacturing, Downstream Manufacturing), By Application (Antisense & RNAi Therapy, Gene Therapy, Cell Therapy, Vaccinology, Other Applications), By End User (Pharmaceutical & Biopharmaceutical Companies, Academic and Research Institutes), and Geography.
Get more insights: https://www.mordorintelligence.com/industry-reports/viral-vector-contract-development-and-manufacturing-organization-cdmo-market?utm_source=openpr
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Adeno-Associated Virus Vectors Manufacturing Market to Reach USD 2.79 Billion by 2030, Fueled by Cell-Line Shifts and Asia-Pacific Expansion here
News-ID: 4138397 • Views: …
More Releases from Mordor Intelligence
Egypt Residential Construction Market to Reach USD 29.96 Billion by 2031 as Gove …
Mordor Intelligence has published a new report on the offering a Egypt Residential Construction comprehensive analysis of trends, growth drivers, and future projections
Egypt Residential Construction Market Overview
According to Mordor Intelligence, the Egypt residential construction market size was valued at USD 18.80 billion in 2025 and expanded to USD 20.32 billion in 2026, with the market forecast to reach USD 29.96 billion by 2031. This growth outlook reflects the…
Canned Meat Market Size to Reach USD 22.69 Billion by 2031 as Protein Demand and …
The global canned meat market size is projected to expand from usd 18.61 billion in 2026 to usd 22.69 billion by 2031, registering a cagr of 4.04% during the forecast period, according to Mordor Intelligence. This steady expansion reflects rising reliance on shelf-stable protein sources, changing household structures, and growing institutional procurement across both developed and emerging economies. The canned meat industry continues to benefit from its dual positioning as…
Canned Alcoholic Beverages Market Size to Reach USD 48.78 Billion by 2030 as RTD …
The Global canned alcoholic beverages market size is projected to expand from USD 34.81 billion in 2025 to USD 48.78 billion by 2030, registering a CAGR of 6.98% during the forecast period, according to Mordor Intelligence. This steady expansion reflects a structural shift in alcohol consumption toward convenient, portable, and premium-ready formats.
The Canned Alcoholic Beverages Industry is benefiting from changing lifestyle patterns, growing demand for ready-to-drink (RTD) options, and increasing…
Automotive Green Tires Market Size Expected to Reach USD 247.9 Billion by 2031 - …
Introduction
The Automotive Green Tires Market is gaining traction as sustainability, fuel efficiency, and emissions reduction become central priorities for automotive manufacturers and regulators. According to Mordor Intelligence, the Automotive Green Tires market size is expected to grow from USD 133.73 billion in 2025 to USD 148.22 billion in 2026, and is forecast to reach USD 247.90 billion by 2031, registering a CAGR of 10.84% during the 2026-2031 forecast period.…
More Releases for Vector
Growing Prevalence Of Vector-Borne Diseases Fuels Vector Control Market: Pivotal …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Vector Control Market Size Growth Forecast: What to Expect by 2025?
The market size of vector control has been experiencing robust growth in the past years, and it's predicted to increase from $20.53 billion in 2024 to $22.01 billion in 2025, with a compound annual growth rate (CAGR) of 7.2%. Factors such as urbanization…
Global Viral Vector Manufacturing Market Size by Application, Type, and Geograph …
USA, New Jersey- According to Market Research Intellect, the global Viral Vector Manufacturing market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The viral vector manufacturing market is witnessing accelerated growth due to the rising demand for gene therapies and vaccines. These vectors are essential tools…
Prominent Viral Vector Manufacturing Market Trend for 2025: Product Innovation I …
How Are the key drivers contributing to the expansion of the viral vector manufacturing market?
The escalation in the occurrence of both cancer and contagious diseases is anticipated to spur the expansion of the viral vector manufacturing market in the future. An infectious disease is a condition caused by a virus or its harmful byproduct which spreads to a susceptible organism through contact with an infected individual, creature, or object. Cancer…
Emerging Lentiviral Vector Market Trend 2025-2034: Technological Advancements In …
How Is the Lentiviral Vector Market Projected to Grow, and What Is Its Market Size?
The lentiviral vector market will grow from $14.37 billion in 2024 to $16.62 billion in 2025, at a CAGR of 15.7%. This market is expanding due to the growing prevalence of genetic disorders, increasing demand for gene delivery systems, biotech and pharmaceutical investments, and regulatory approvals for related therapies.
The lentiviral vector market is expected to grow…
Viral Vector Manufacturing Market Report 2024 - Viral Vector Manufacturing Marke …
"The Business Research Company recently released a comprehensive report on the Global Viral Vector Manufacturing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Adeno-Associated Virus Vector Manufacturing Market - Building Better Therapies: …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Adeno-Associated Virus Vector Manufacturing Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Adeno-Associated Virus Vector Manufacturing provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and…
